Table 4

Linear regressions for 10-year risk (continuous %) as per the Framingham Risk Score, Pooled Cohort Equations and QRISK3 algorithm

	Unadjusted		Adjusted
	β-coefficient (95% CI)	P value	Adjusted β-coefficient (95% CI)	P value
Framingham Risk Score
PA status	1.39 (–0.27 to 3.05)	0.10	−0.32 (–2.99 to 2.34)	0.81
Absolute deviation of systolic BP from median systolic BP	0.07 (–0.003 to 0.14)	0.06	0.01 (–0.09 to 0.11)	0.82
Interaction term between PA status and absolute deviation of systolic BP from median systolic BP	–	–	0.12 (–0.02 to 0.27)	0.09
Pooled Cohort Equations
PA status	2.89 (–0.72 to 6.51)	0.12	3.27 (–2.62 to 9.16)	0.27
Absolute deviation of systolic BP from median systolic BP	−0.002 (–0.18 to 0.17)	0.98	0.02 (–0.22 to 0.25)	0.88
Interaction term between PA status and absolute deviation of systolic BP from median systolic BP	–	–	−0.03 (–0.38 to 0.32)	0.87
QRISK3
PA status	0.48 (–2.44 to 3.39)	0.75	−2.57 (–7.24 to 2.09)	0.28
Absolute deviation of systolic BP from median systolic BP	0.24 (0.11 to 0.36)	<0.001	0.11 (–0.10 to 0.31)	0.31
Interaction term between PA status and absolute deviation of systolic BP from median systolic BP	–	–	0.21 (–0.05 to 0.47)	0.12

Each of the models was run independently. The Framingham Risk Score model included 242 participants; the Pooled Cohort Equations model included 141 participants; and the QRISK3 model included 217 participants.
BP, blood pressure; PA, primary aldosteronism .